Cipla’s arm recalls 7992 bottles of Difluprednate Ophthalmic Emulsion in US market

22 Aug 2022 Evaluate

Cipla’s New Jersey-based unit -- Cipla USA, Inc is recalling 7,992 bottles of Difluprednate Ophthalmic Emulsion, used to treat swelling and pain after eye surgery, in the US market. The recalling of the lot is due to ‘lack of assurance of sterility’. There were complaints regarding ''defective container closure’. The affected lot was manufactured in India and marketed in the US by Cipla USA, Inc.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1345.70 19.40 (1.46%)
25-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1763.80
Dr. Reddys Lab 1306.60
Cipla 1345.70
Zydus Lifesciences 919.40
Lupin 2292.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×